Acadia Healthcare (NASDAQ:ACHC) Issues FY 2025 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 2.500-2.800 for the period, compared to the consensus EPS estimate of 3.360. The company issued revenue guidance of $3.3 billion-$3.4 billion, compared to the consensus revenue estimate of $3.4 billion. Acadia Healthcare also updated its Q1 2025 guidance to EPS.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ACHC. Cantor Fitzgerald restated a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. KeyCorp raised shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective for the company in a report on Tuesday, January 7th. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Royal Bank of Canada reissued an “outperform” rating and issued a $64.00 target price on shares of Acadia Healthcare in a research note on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Stock Down 1.8 %

ACHC traded down $0.74 during trading on Thursday, hitting $40.26. 2,625,423 shares of the company’s stock traded hands, compared to its average volume of 1,419,476. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $86.67. The company’s 50 day simple moving average is $42.22 and its two-hundred day simple moving average is $52.30. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market capitalization of $3.74 billion, a price-to-earnings ratio of 13.20, a PEG ratio of 1.46 and a beta of 1.30.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.64 EPS for the quarter, missing the consensus estimate of $0.75 by ($0.11). Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.